Role of Regional Lung Compliance and Dynamic Transpulmonary Driving Pressure in the Liberation Difficulty in Tracheostomized Patients Receiving Prolonged Mechanical Ventilation
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · May 26, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying why some patients with tracheostomies have difficulty transitioning off mechanical ventilation after a long period of use. Specifically, it looks at how different factors related to lung function, such as lung pressure and how well different parts of the lungs are working, may affect a patient's ability to pass a breathing test and breathe on their own. Understanding these factors can help healthcare providers improve care for patients who need prolonged mechanical ventilation.
To be eligible for this trial, participants must be at least 20 years old, have been on a ventilator for at least 14 days after a tracheostomy, and require less than 50% oxygen while on the ventilator. However, those with unstable vital signs, certain lung conditions like asthma or COPD, or specific recent surgeries may not be able to participate. If someone joins the study, they will undergo various tests to assess their lung function and may receive additional care based on the findings. This research aims to improve the chances of successfully transitioning patients off mechanical ventilation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Post-tracheostomy patients who are transferred to the subacute respiratory care ward of National Taiwan University Hospital must use respirators for at least 14 days;
- • Be at least 20 years old;
- • The oxygen concentration required when using the respirator does not exceed 50%
- Exclusion Criteria:
- • The vital signs are unstable or require continuous use of vasopressors;
- • Pregnancy;
- • Chronic obstructive pulmonary disease or asthma;
- • Those who have contraindications to the placement of esophageal pressure balloons, such as abnormal blood coagulation, esophageal varices, and those who have undergone esophageal or gastric surgery in the past six months;
- • Those who have contraindications to the use of electrical impedance tomography, such as heart rhythm regulators.
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei City, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported